Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
15:08:25 EDT Tue 07 May 2024
Enter Symbol
or Name
USA
CA



News for U:BICX from 2023-05-08 to 2024-05-07 - 10 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-03 08:30U:BICXNews ReleaseBioCorRx Pharmaceuticals Inc. Awarded New Patent for Novel Compound to Treat Pain, Depression, and Schizophrenia
2024-04-02 08:30U:BICXNews ReleaseBioCorRx Reports Business Update for 2023
2024-02-28 10:50U:BICXNews ReleaseBioCorRx Pharmaceuticals Inc. Awarded NIDA Grant of Approximately $11 million Over Three Years for Research on BICX104, a Naltrexone Implant in Combination with Bupropion for the Treatment of MUD
2024-02-08 09:53U:BICXNews ReleaseBioCorRx Pharmaceuticals Inc. Appoints Neuroscientist Dr. Kate DeVarney to the Board of Directors
2024-01-09 08:30U:BICXNews ReleaseBioCorRx Appoints Renowned Investment and Capital Markets Executive Louis Lucido as President
2023-11-14 12:53U:BICXNews ReleaseBioCorRx Reports Business Update for the Third Quarter of 2023
2023-08-15 09:00U:BICXNews ReleaseBioCorRx Submits Expanded Access Treatment Protocol to FDA for BICX104, Implantable Biodegradable Naltrexone Pellet for Treatment of Opioid Use Disorder
2023-08-14 16:34U:BICXNews ReleaseBioCorRx Reports Business Update for the Second Quarter of 2023
2023-07-18 08:30U:BICXNews ReleaseBioCorRx Submits Fast Track Application to FDA for BICX104, an Implantable Biodegradable Naltrexone Pellet for The Treatment of Opioid Use Disorder
2023-05-16 08:30U:BICXNews ReleaseBioCorRx Provides Business Update for the First Quarter of 2023